Synthesis, anticancer, and antioxidant activity study of some new 3-(4,6-dihydroxypyrimidin-2-yl) -2-(aryl)thiazolidin-4-ones
Abstract
This study aims to synthesize a series of pyrimidine derivatives linked to active units and evaluate their anticancer and antioxidant activities. First, several Schiff bases were synthesized by the condensation of 2-aminopyrimidine- 4,6-diol with suitable aromatic aldehydes. Subsequently, Schiff bases were subjected to a cyclocondensation reaction with 2-mercapto-2-phenylacetic acid to obtain the target compounds, namely, 3-(4,6-dihydroxypyrimidin-2-yl)-2-(aryl) thiazolidin-4-ones (5a-d). The synthesized compounds were screened in vitro using the 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide assay against two breast cell lines: the cancer cell Michigan Cancer Foundation (MCF)-7 and the healthy cell MCF10A. The test results showed that some of these derivatives have encouraging anti-proliferation activity against MCF-7 cells, while their toxicity was very low towards normal MCF10A cells. In addition, results of the 1,1-diphenyl-2-picrylhydrazil assay revealed superior radical-scavenging ability of some of the new compounds with inhibition percentages reaching approximately 92.3% and 90.6% compared to ascorbic acid.. KEYWORDS :Anticancer, Antioxidant, Pyrimidine-4,6-diol, Michigan cancer foundation-7 cells, Schiff's bases, Thiazolidin-4-one.